|
Home : Environmental Toxins : Mesothelioma : Newsfeeds : Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement ... Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement ...
MSN MoneyCentral - ONCONASE, the company's lead drug candidate, is currently being evaluated as a treatment for unresectable malignant mesothelioma (UMM) in a confirmatory Phase IIIb clinical trial. Under the agreement, Alfacell has granted BL&H exclusive rights in ...
Find a Mesothelioma Lawyer Now
This form is secure and encrypted. More information about secure forms and your privacy here.
|




